Evidence map›Paper›PMID 42687020›Full record

ReviewCellular & molecular immunology2026

The NLRP3 inflammasome at the crossroads of innate immune signaling and cell death.

Nanyang Xiao, Zexuan Lu, Destiny K Cooper, Jueqi Chen

Abstract readReview
In one paragraph

Review in Cellular & molecular immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nanyang XiaoDepartment of Microbiology, University of Chicago, Chicago, IL, USA.
Zexuan LuDepartment of Microbiology, University of Chicago, Chicago, IL, USA.
Destiny K CooperDepartment of Microbiology, University of Chicago, Chicago, IL, USA.
Jueqi ChenDepartment of Microbiology, University of Chicago, Chicago, IL, USA. jueqi@uchicago.edu.

Funding

Trans-Golgi Network Remodeling by Microbial FactorsR35GM151390 · NIGMS · UNIVERSITY OF CHICAGO · PI Jueqi Chen · 2023 to 2026
$1.8M
U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM151390
6 · The paper itself

Abstract

The NLRP3 inflammasome is a central signaling pathway of innate immunity that orchestrates host defense and inflammatory responses through the activation of proinflammatory cytokines and the induction of pyroptotic cell death. Accumulating evidence indicates that NLRP3 functions within an extensive network of innate immune and cell death pathways. Reciprocal interactions between NLRP3 and other pattern-recognition receptor pathways, including Toll-like receptors, DNA-sensing cGAS-STING signaling, and RNA-sensing RIG-I/MDA5-MAVS signaling, shape the magnitude and duration of inflammatory responses during pathogen infection. Moreover, substantial crosstalk exists between NLRP3 and other inflammasomes and programmed cell death pathways, reflecting the integrated nature of cellular stress and inflammatory signaling. In this review, we summarize recent advances in our understanding of the molecular mechanisms that mediate these interactions, focusing on shared signaling components, organelle dynamics, posttranslational modifications, and feedback regulatory circuits. We further discuss how these signaling networks contribute to infectious and inflammatory diseases and highlight key unanswered questions and emerging areas of investigation that may guide the development of therapies targeting inflammasome-associated pathologies.

Indexed as

Immunity, InnateInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinSignal TransductionAnimalsCell DeathcGAS-STING Signaling PathwayHumansInflammationInnate Immunity RecognitionInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinCell deathInflammasomeInnate immunity

Identifiers

PMID42687020
PMCPMC13623877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.